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Role of the T Cell Receptor a Chain
in Stabilizing TCR-Superantigen-MHC
Class II Complexes
simultaneous interaction of the SAG with the TCR and
with MHC class II molecules on an antigen-presenting
cell (APC). Immunological (Kotzin et al., 1993; Scherer
et al., 1993; Webb and Gascoigne, 1994), X-ray crystallo-
graphic (Fields et al., 1996; Li et al., 1998, 1999), and
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An analysis of Vb8.11 T cell hybridomas from Mls-12
Summary mice in which Mls-1-reactive T cells were not deleted
revealed a skewing of a chain usage between Mls-1-
Superantigens (SAGs) activate T cells by simultane- reactive and Mls-1-nonreactive hybridomas, such that
ously binding the Vb domain of the TCR and MHC hybridomas expressing Va11.1 were biased toward
class II molecules on antigen-presenting cells. The Mls-1 reactivity, whereas hybridomas expressing Va2,
preferential expression of certain Va regions among Va8, or Va11.3 were biased against reactivity (Smith et
SAG-reactive T cells has suggested that the TCR a al., 1992). These Vb8.11 hybridomas exhibited a similar
chain may modulate the level of activation through an pattern of a chain bias in their reactivity toward SEB.
interaction with MHC. We demonstrate that the TCR
Similarly, Borrero et al. (1995) found that Va4 is ex-
a chain is required for maximum stabilization of the
pressed by Vb61 T cell hybridomas that react with SEB
TCR-SAG-MHC complex and that the a chain in-
but not by Vb61 hybridomas that do not respond to this
creases the half-life of the complex to match those of
SAG. Transfection experiments demonstrated that theTCR-peptide/MHC complexes. The site on the TCR a
Va4 a chain transferred SEB responsiveness regardlesschain responsible for these effects is CDR2. Thus, the
of whether the Vb6 b chain was derived from a respon-overall stability of the TCR-SAG-MHC complex is de-
sive or nonresponsive hybridoma (Donson et al., 1997).termined by the combination of three distinct interac-
The preferential expression of certain Va regions amongtions: TCR-SAG, SAG-MHC, and MHC-TCR.
SAG-reactive T cells, along with evidence of a functional
interaction between the TCR a chain and MHC class II
in the TCR-SAG-MHC complex (Deckhut et al., 1994;Introduction
Labrecque et al., 1994), has been interpreted as an indi-
cation that these particular Vas interact with MHC moreSuperantigens (SAGs) are a class of immunostimulatory
favorably than other Vas during SAG-mediated T celland disease-causing proteins of viral or bacterial origin
activation (Woodland and Blackman, 1993; Webb andwith the ability to activate large fractions (5%±20%) of
Gascoigne, 1994; Blackman and Woodland, 1996; Don-the T cell population. SAGs include self-antigens, such
son et al., 1997).as the minor lymphocyte-stimulating antigens (Mls) en-
To help explain the observed influence of the TCR acoded by endogenous murine retroviruses, as well as
chain on SAG reactivity, we have constructed modelsforeign antigens, such as staphylococcal and strepto-
coccal pyrogenic toxins (Bohach et al., 1990; Kotzin et of the TCR-SEC3-peptide/MHC class II complex based
al., 1993; Scherer et al., 1993; Webb and Gascoigne, on the crystal structures of the VbCb-SEC3 (Fields et
1994; Bohach, 1997). T cell activation by SAGs requires al., 1996) and VbCb-SEB (Li et al., 1998) complexes, the
SEB-peptide/HLA-DR1 complex (Jardetzky et al., 1994),
and several different TCR ab heterodimers (Garboczi et#To whom correspondence should be addressed (e-mail: mariuzza@
indigo2.carb.nist.gov). al., 1996; Garcia et al., 1996; Housset et al., 1997; Wang
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effectively cross-link the T cell and APC at the nanomo-
lar concentrations commonly employed in T cell stimula-
tion assays, since the vast majority of SAG molecules
should be unbound under these conditions (Proft and
Fraser, 1998). The problem is less severe for peptide/
MHC because the peptide is, in effect, irreversibly bound
to the MHC molecule. Thus, some mechanism(s) must
exist to permit SAGs to trigger T cells at concentrations
orders of magnitude below their dissociation constants
(KDs) for TCR or MHC. One possibility is that accessory
molecules such as CD4 help stabilize the TCR-SAG-
MHC complex sufficiently for activation to occur. How-
ever, T cell stimulation by bacterial SAGs is largely inde-
pendent of CD4 or CD8 (Kotzin et al., 1993). Another
possibility is that the overall stability of the TCR-SAG-
MHC complex is considerably greater than would be
expected from considering the TCR-SAG and SAG-MHC
interactions independently. That is, the binding of SAGs
may be a cooperative process in which the SAG-MHC
complex binds the TCR with greater affinity than does
the SAG alone or in which the TCR-SAG complex binds
MHC with greater affinity than does the free SAG. Co-
operativity may occur in one of several ways: binding
of the SAG to MHC induces a conformational change
in the SAG that increases its affinity for the TCR, binding
of the SAG to TCR induces a conformational change in
the SAG that increases its affinity for MHC, or TCR-MHC
interactions occur in the TCR-SAG-MHC complex that,Figure 1. Model of the TCR-SEC3-Peptide/MHC Class II Complex
combined with TCR-SAG and SAG-MHC interactions,The model was constructed according to Li et al. (1998) by least-
contribute to its overall stabilization. With respect tosquares superposition of the 14.3.d VbCb-SEC3 complex (Fields et
possible conformational changes upon binding, X-rayal., 1996), the SEB-peptide/HLA-DR1 complex (Jardetzky et al.,
1994), and the 2C TCR VaCa/VbCb heterodimer (Garcia et al., 1998), crystallographic studies of SAG-MHC (Jardetzky et al.,
which uses the same Vb element (mouse Vb8.2) as the 14.3.d TCR. 1994; Kim et al., 1994; Dessen et al., 1997) and TCR b
The CDR2 loop of the 2C Va domain is labeled. The C terminus of chain-SAG (Fields et al., 1996; Li et al., 1998) complexes
SEC3, used for attachment to bacteriophage gene III protein (see
have revealed that there are no major structural re-text), is indicated. The 44±47 loop (KFLAH) of SEC3 that was targeted
arrangements in any of the individual components as afor saturation mutagenesis is shown in red with side chains included.
result of complex formation that could increase the affin-Models (data not shown) of the TCR-SEC3-peptide/MHC class II
complex were also constructed using TCRs A6 (Garboczi et al., ity of the SAG for TCR or MHC. On the other hand, the
1996) and N15 (Wang et al., 1998). In both cases, the putative con- model in Figure 1 predicts that the TCR Va domain
tacts between the TCR and the MHC b1 helix are mediated by Va may interact with the MHC b1 helix, thereby potentially
CDR2, despite differences in Va/Vb domain orientation and Va CDR2 increasing the stability of the TCR-SAG-MHC complex
loop structure (Li et al., 1998).
to match that of the TCR-peptide/MHC complex.
To investigate the possible role of the TCR a chain in
stabilizing the TCR-SAG-MHC complex, we have mea-
et al., 1998). As shown in Figure 1, the models predict sured the binding of SEC3 to recombinant forms of two
that the Va domain interacts with the MHC b1 helix different TCRs in the presence and absence of a human
through its CDR2 loop, suggesting that TCR-MHC con- MHC class II molecule, HLA-DR1. We show that soluble
tacts may help stabilize the TCR-SAG-MHC complex. HLA-DR1 significantly enhances the binding of SEC3 to
However, the extent of the Va-MHC interaction is vari- the ab TCR heterodimers but has no effect on the bind-
able and depends on the geometry of Va/Vb domain ing of SEC3 to the TCR b chain alone. We find that the
association and on the structure of the Va CDR2 loop TCR a chain increases the half-life of the TCR-SEC3-
(Li et al., 1998). We hypothesized that this variability, DR1 complex to a value comparable to those reported
by stabilizing the TCR-SAG-MHC complex to different for specific TCR-peptide/MHC class I or class II com-
degrees, could account for the preferential expression plexes (1±60 s) (Corr et al., 1994; Matsui et al., 1994;
of certain Va regions among T cells reactive with a par- Alam et al., 1996; Lyons et al., 1996; Kersh et al., 1998).
ticular SAG. However, no direct proof of a stabilizing Using phage display technology to isolate variants of
effect of the TCR a chain on ternary complex formation SEC3 with up to 60-fold tighter binding to HLA-DR1,
has been reported. we show that increasing the affinity of the SAG-MHC
The high efficiency with which SAGs trigger T cells, interaction further extends the half-life of the ternary
which is comparable to the efficiency of activation by complex, as predicted by a model involving direct TCR-
specific peptide/MHC complexes (Viola and Lanzavec- MHC interactions. Finally, we have used site-directed
chia, 1996), presents a paradox. With affinities for both mutagenesis to identify Va CDR2 as the apparent site
TCR and MHC class II in the micromolar range (Li et on the TCR a chain responsible for maximizing the sta-
bility of the TCR-SAG-MHC complex.al., 1999), it is difficult to understand how SAGs can
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Results and Discussion
The TCR a Chain Stabilizes the
TCR-SAG-MHC Complex
A previous BIAcore study showed that the binding of
SEB to an immobilized human TCR is significantly in-
creased by the addition of soluble HLA-DR1 (Seth et al.,
1994), suggesting that the affinity of the TCR for SEB
complexed with MHC class II is greater than its affinity
for the SAG alone. To determine the structural basis for
this effect, we utilized soluble forms of the associated
14.3.d ab TCR (mouse Va4.1/Vb8.2) and of the isolated
14.3.d b chain. The ab heterodimer was secreted by
Drosophila cells transfected with a and b chains trun-
cated before their transmembrane regions, while the
unpaired b chain was expressed by myeloma cells trans-
fected with truncated b chain alone (Bentley et al., 1995).
As a source of MHC class II, we used soluble HLA-DR1
produced by Sf21 insect cells infected with a recombi-
nant baculovirus encoding truncated DRa and DRb
chains (Stern and Wiley, 1992; Murthy and Stern, 1997).
The empty class II molecules were loaded with either
influenza virus hemagglutinin peptide 306-318 (HA 306-
318) or with the YAK peptide (Natarajan et al., 1999), a
derivative of HA 306-318 bearing multiple alanine substi-
tutions.
To determine if simultaneous binding of 14.3.d TCR
and HLA-DR1 to SEC3 leads to enhanced stability of
the TCR-SAG-MHC complex, soluble TCR, soluble HLA-
DR1/HA 306-318, and a mixture of the two were injected
over immobilized SEC3 (Figure 2A). To estimate the in-
crease in resonance units (RU) resulting from the non-
specific effect of protein on the bulk refractive index,
the binding of TCR and MHC to a control surface with
no immobilized SAG was also measured (Figure 2A).
No specific binding of HLA-DR1 was detectable at the
concentration used in the assay (1.5 mM), as expected
from our estimate of 270 mM for the KD of the SEC3-
DR1 interaction (see below). On the other hand, the TCR
heterodimer at a concentration of 12 mM produced a Figure 2. BIAcore Analysis of TCR and MHC Binding to SEC3
significant response, consistent with the affinity of the (A) Sensograms of 12 mM 14.3.d ab TCR (green), 1.5 mM soluble
14.3.d b chain for SEC3 (KD 5 3.0 mM) (Leder et al., HLA-DR1 (blue), or 12 mM 14.3.d ab TCR and 1.5 mM HLA-DR1 (red)
1998). The signal for the mixture of TCR and MHC was injected over a surface coupled with SEC3 (1100 RU, approximately
80% active) or over a blank control surface, as indicated below eachsignificantly greater than the sum of the individual re-
overlay plot.sponses, as also reported for SEB (Seth et al., 1994).
(B) Sensograms of 19 mM 14.3.d TCR b chain (green), 1.5 mM solubleMoreover, the dissociation kinetics were clearly slower
HLA-DR1 (blue), or 19 mM 14.3.d TCR b chain and 1.5 mM HLA-for the mixture of TCR and MHC than for TCR alone DR1 (red) injected over a surface coupled with SEC3 (1100 RU,
(Figure 2A). Identical results were obtained using HLA- approximately 80% active) or over a blank control surface.
DR1 loaded with YAK, showing that the effect is not (C) Sensograms of 6 mM SEC3 (green), 2.5 mM soluble HLA-DR1
peptide specific. To ascertain whether the increased (blue), or 6 mM SEC3 and 2.5 mM HLA-DR1 (red) injected over immo-
bilized 14.3.d ab TCR (3000 RU, approximately 60% active), 14.3.dsignal and decreased off-rate were dependent on the
TCR b chain (2400 RU, about 40% active), or over a blank controlTCR a chain, we repeated the experiment, but this time
surface. The percentage of active ab TCR or TCR b chain wasreplacing the 14.3.d TCR heterodimer with the corre-
estimated by Scatchard analysis using SEC3.
sponding soluble b chain. As seen in Figure 2B, the
response elicited by the mixture of 14.3.d b chain
and HLA-DR1 did not exceed the sum of the responses
14.3.d TCR to immobilized SEC3 clearly shows signs ofto the two proteins when injected individually. The
aggregation: biphasic association (a fast initial increaserapid dissociation kinetics of b chain binding to SEC3
of about 375 RU followed by a much slower increase ofwere likewise unaltered by the inclusion of soluble MHC
about 50 RU) and elevated baseline upon washing (Fig-class II.
ure 2A). To rule out the possibility that aggregation of theProtein aggregation in the relatively dense dextran
14.3.d TCR is somehow responsible for the enhancedmatrix of the sensor chip can present serious difficulties
binding to immobilized SEC3 observed in the presencein the interpretation of BIAcore results (Davis et al.,
1998). Indeed, the sensogram for the binding of soluble of HLA-DR1, the orientation of the assay was reversed.
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Thus, we immobilized the TCR instead of the SAG and mutants of SEC3 with increased affinity for MHC and
repeated the above experiments using SEC3, soluble by comparing the ability of these mutants to stabilize
HLA-DR1, and a combination of the two. There are no the TCR-SAG-MHC complex with that of the wild-type
signs of significant aggregation in the binding of SEC3 SAG.
to immobilized 14.3.d TCR: the equilibrium binding level
was reached within seconds and the response rapidly Isolation of SEC3 Variants with Increased Affinity
returned to baseline upon completion of the injection for HLA-DR1 from a Phage Display Library
(Figure 2C). Furthermore, the affinity of the immobilized The high degree of sequence homology between SEB
ab TCR for SEC3, as measured by Scatchard analysis and SEC3 (65% identical), their very similar three-dimen-
under equilibrium binding conditions, was indistinguish- sional structures (Swaminathan et al., 1992; Hoffmann
able from that of the immobilized 14.3.d b chain alone, et al., 1994), and the nearly identical ways in which they
approximately 20 mM (data not shown), consistent with bind TCR (Fields et al., 1996; Li et al., 1998) make it
the predicted lack of direct contacts between SEC3 and reasonable to assume that SEB and SEC3 possess simi-
the TCR a chain in the TCR b-SEC3 complex (Fields et lar binding sites for MHC class II. In the structure of the
al., 1996). However, the binding of SEC3 to immobilized SEB-HLA-DR1 complex (Jardetzky et al., 1994), SEB
TCR was markedly enhanced by soluble HLA-DR1, such binds to the a1 domain of DR1. The interface displays
that the response to a mixture of SEC3 and DR1 was two main structural features: a salt bridge between SEB
approximately twice the sum of the responses to the residue Glu67 and DR1 a chain residue Lys39 and a
individual components. The apparent off-rate was also protruding hydrophobic loop composed of SEB residues
decreased, compared with that for the binding of SEC3 43±47 (QFLYF) that fits into a predominantly hydropho-
alone to TCR. Injecting the same samples over immobi- bic depression on the a1 domain of DR1 formed by the
lized 14.3.d b chain confirmed the requirement of the first and third turns of the b sheet and the N-terminal
TCR a chain for the formation of complexes with in- portion of the a-helix (Figure 1). The glutamic acid at
creased stability, since the sensogram obtained by in- SEB position 67 is conserved (or conservatively substi-
jecting SEC3 alone is nearly superimposable on that tuted) in SEC1±3, SEA, SED, SEE, SPEA, SPEC, and
obtained by injecting the mixture of SEC3 and HLA-DR1 SSA, whereas the sequence of the 44±47 loop is more
(Figure 2C). These results are in agreement with those variable. We therefore targeted the corresponding re-
obtained using immobilized SAG and are therefore inde- gion of SEC3 (KFLAH) for saturation mutagenesis in
pendent of the orientation of the assay. Similar results search of variants with increased affinity for HLA-DR1.
were obtained using SEB (data not shown). A library of approximately 1.3 3 107 unique clones was
The effect of the TCR a chain in stabilizing the TCR- displayed on the surface of filamentous bacteriophage
SAG-MHC complex may be understood in terms of the by fusion to the N terminus of gene III protein (see Experi-
model in Figure 1 in which the Va domain of the TCR is mental Procedures for details). In the structure of the
predicted to interact with the MHC b1 helix. This sug- SEB-HLA-DR1 complex (Jardetzky et al., 1994), the C
gests that the overall stability of the complex is deter- terminus of the SAG is distant from the MHC combining
mined by the interplay of three distinct interactions: TCR
site (Figure 1); consequently, attachment of gene III
b chain-SAG, SAG-MHC a chain, and MHC b chain-
protein at this position should not interfere with MHC
TCR a chain. A test of this hypothesis was designed as
binding. The phage library was selected by panning on
follows.
immobilized HLA-DR1. Several clones with increasedThe formation of a ternary complex involving three
reactivity toward this MHC were identified, and two withdifferent components (e.g., TCR, SAG, and MHC) may
either medium (SEC3 3B1) or high (SEC3 3B2) reactivityoccur by one of two general mechanisms. In the simpler
were chosen for further characterization. Their aminocase, only one of the three components is able to bind,
acid sequences at positions 43±47 are shown in Figureor cross-link, the other two. Alternatively, each of the
3D. Soluble protein was produced for each mutant bythree components can form productive interactions with
transfecting phagemid DNA into a nonsuppressor Esch-the other two. In principle, it is possible to discriminate
erichia coli strain, ensuring translation of only the SEC3between these mechanisms by examining the effects
part of the SEC3-gene III fusion (Hoogenboom et al.,of altering the affinity of individual interactions on the
1991). The affinities of the SEC3 mutants for HLA-DR1stability of the overall complex. For example, if the TCR-
were measured by BIAcore (Figures 3A and 3B). Be-SAG-MHC complex is formed by the SAG simply cross-
cause we were unable to directly couple DR1 to thelinking TCR and MHC (TCR-SAG and SAG-MHC interac-
sensor surface with satisfactory retention of SAG-bind-tions only, with no TCR-MHC interaction), increasing the
ing activity, we first coupled SEA to the matrix and thenaffinity of the SAG-MHC interaction should not affect
used its Zn21-dependent, high-affinity binding site forthe half-life of the ternary complex, as measured in a
the DR1 b chain (Abrahmsen et al., 1995; Hudson et al.,BIAcore assay in which the TCR is immobilized, since
1995; Kozono et al., 1995) to capture the MHC molecule.the affinity of the TCR for the SAG-MHC complex will
This site is distinct from the low-affinity SEC3 site onbe the same as its affinity for the free SAG. If, on the
the DR1 a chain, such that one SEA molecule can simul-other hand, TCR-MHC interactions contribute to stabi-
taneously bind two SAG molecules (Tiedemann et al.,lizing the TCR-SAG-MHC complex, increasing the affin-
1995). Wild-type SEC3 and SEC3 mutants were injectedity of the SAG-MHC interaction should increase the half-
over a range of concentrations and concentration-life of the ternary complex since, in this case, the affinity
dependent binding profiles recorded (Figure 3A). Affinit-of the TCR for the SAG-MHC complex will be greater
ies for HLA-DR1 were determined by Scatchard analysisthan its affinity for the SAG alone. We have tested this
prediction by using phage display technology to isolate under equilibrium binding conditions (Figure 3B). The
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Figure 3. Characterization of SEC3 Mutants
with Increased Affinity for MHC Class II Se-
lected from a Phage Display Library
(A) Sensograms showing binding of wild-type
SEC3 (SEC3 WT), SEC3 3B1, and SEC3 3B2 to
immobilized HLA-DR1 or to a control surface.
Initial concentrations of the SAGs (SEC3 WT,
130 mM; SEC3 3B1, 42 mM; and SEC3 3B2,
27 mM) were serially diluted 2-fold, and sam-
ples at four or five different concentrations
were injected over HLA-DR1 bound to SEA
through its high-affinity site for the DR1 b
chain. The control (blank) was the SEA-cou-
pled surface prior to the injection of HLA-
DR1. Due to differences in the amount of
bound MHC at the time of injection, all senso-
grams were normalized to facilitate compar-
isons.
(B) Scatchard analysis of the binding of SEC3
WT, SEC3 3B1, and SEC3 3B2 to HLA-DR1
with data derived from (A) after correction for
the bulk effect. The data were fitted to straight
lines; KDs were calculated directly from the
slopes.
(C) Proliferation of lymph node T cells from
RAG22/2 14.3.d TCR transgenic mice in the
presence of SEC3 WT, SEC3 3B1, or SEC3
3B2. Mouse fibroblasts transfected with
genes encoding HLA-DR1 were used as
APCs. The SAG concentrations are indicated
with the different symbols. Proliferation re-
sults at 48 hr are shown here. The results
were qualitatively the same at 72 hr.
(D) Table showing the sequences of wild-type
and mutant SEC3 proteins at positions 43±47.
The KDs for binding to HLA-DR1, determined from the Scatchard plots in (B), are given. The effective dose (ED) of each SAG is expressed as
the concentration (nM) required to induce 25% of maximum T cell proliferation in (C).
KDs for the binding of SEC3 3B1 and SEC3 3B2 were 14 SEC3 3B1 (KD 5 14 mM). In order to rule out the possibility
that the enhanced binding we observed for SEC3 3B1and 4.6 mM, respectively, compared with 270 mM for
wild-type SEC3. Thus, SEC3 3B1 and SEC3 3B2 bind and SEC3 3B2 is simply due to increased binding of
MHC to the mutant SAGs bound to immobilized TCR,HLA-DR1 approximately 20- and 60-fold more tightly,
respectively, than the wild-type protein. The affinities of independently of any TCR-MHC interaction, we re-
peated the experiment using immobilized 14.3.d b chainthe mutants for the 14.3.d TCR were similar to that of
wild-type SEC3. The abilities of SEC3 3B1 and SEC3 alone (data not shown). In this case, injection of SEC3
3B1 or SEC3 3B2 premixed with DR1 gave the same3B2 to induce proliferation of resting lymph node T cells
bearing the 14.3.d TCR from RAG-22/2 TCR transgenic result as injection of wild-type SEC3 premixed with DR1,
with no increase in complex formation. This is in factmice were measured using mouse fibroblasts express-
ing HLA-DR1 as APCs (Figure 3C). The results, ex- consistent with the affinities of the mutants for DR1:
even for SEC3 3B2 (KD 5 4.6 mM), one may calculatepressed as the dose of each SAG required to induce
25% of maximum T cell proliferation, show that mito- that only 7% of the SAG molecules would be complexed
with MHC at the concentrations employed if the SAGgenic potency increases with increasing affinity for MHC
(Figure 3D), in agreement with previous results (Leder simply cross-linked TCR and MHC in the absence of
et al., 1998). any TCR-MHC interactions, such that MHC would have
only a relatively small effect on the total response (a
12% increase in RU compared with the approximatelyKinetic Analysis of TCR-SAG-MHC Complex
300% increase actually observed).Formation as a Function of SAG-MHC Affinity
A visual comparison of the dissociation phases inTo determine if the increase in MHC affinity had the
Figure 4A suggested that increasing the affinity of thepredicted effect on the stability of the TCR-SAG-MHC
SAG-MHC interaction also increased the half-life of thecomplex, wild-type SEC3, SEC3 3B1, and SEC3 3B2
TCR-SAG-MHC complex, as predicted above. To deter-were injected over immobilized 14.3.d TCR, either alone
mine whether this was indeed the case, we measuredor premixed with 1 mM soluble HLA-DR1 (Figure 4A).
the off-rates for the ternary complexes formed by wild-Both mutants displayed greater degrees of enhanced
type SEC3 (Figure 4B) and by SEC3 3B2 (Figure 4C).binding than the wild-type SAG. Moreover, there was a
Fixed concentrations of each SAG (3 mM for wild-typecorrelation between MHC affinity and the amount of
SEC3 and 6 mM for the mutant) were injected over im-enhancement, such that SEC3 3B2 (KD 5 4.6 mM)
showed significantly more complex formation than mobilized 14.3.d TCR in combination with increasing
Immunity
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concentrations of soluble HLA-DR1. The sensograms
showed a concentration-dependent increase in binding,
and the dissociation phases fitted readily to a single
exponential equation, yielding koff values of 0.091 6
0.002 s21 (t1/2 5 7.6 s) for wild-type SEC3 and 0.024 6
0.001 s21 (t1/2 5 29 s) for SEC3 3B2. In contrast, the half-
life of the ternary complex formed by the 14.3.d b chain
alone was far too short to accurately measure by BIA-
core. Representative fits (inserts in Figures 4B and 4C)
show how remarkably well the data conform to a
pseudo-first-order reaction. Thus, increasing the affinity
of the SAG-MHC interaction increases the half-life of
the ternary complex, as predicted above.
It is noteworthy that the half-lives of the ternary com-
plexes formed by SEC3 and SEC3 3B2 (7.6 and 29 s,
respectively) fall within the range measured for specific
TCR-peptide/MHC class I or class II complexes (1±60 s)
(Corr et al., 1994; Matsui et al., 1994; Alam et al., 1996;
Lyons et al., 1996; Kersh et al., 1998). This indicates that
the SAG-MHC complex effectively mimics the kinetics
of interaction of peptide/MHC with the TCR, even though
the binding of SAGs to MHC class II is far weaker than
that of specific peptides (Margulies et al., 1996). Stabili-
zation of the TCR-SAG-MHC complex to a level similar
to that of the TCR-peptide/MHC complex requires the
TCR a chain, since the b chain alone is unable to form
ternary complexes of comparable stability.
A Single Amino Acid Change in Va CDR2 Eliminates
the Contribution of the TCR a Chain to Ternary
Complex Stabilization
According to our model of the TCR-SEC3-MHC complex
(Figure 1), TCR-MHC contacts (,4 AÊ ) are predicted be-
tween Va CDR2 and the MHC b1 helix; this specific
interaction should therefore be responsible, at least in
part, for the observed stabilization of the ternary com-
plex by the TCR a chain. As shown in Figure 5A, the
putative interaction is primarily mediated by Va CDR2
Ser51 (Li et al., 1998), which is located at the tip of the
CDR loop in the crystal structures of the 2C, A6, and
B7 TCRs (Garboczi et al., 1996; Garcia et al., 1996; Ding
et al., 1998) and that is the most frequently occurring
residue at this position in Va sequences (Arden et al.,
1995; Clark et al., 1995). This Va residue is predicted to
contact Thr77 of the HLA-DR1 b chain (Figure 5A), in
agreement with the finding that mutations at position
77 of the b chains DR1 and I-Ek have been found to
greatly reduce the T cell response to SEB without affect-
ing binding of the SAG to MHC class II (Deckhut et al.,Figure 4. Effects of the Affinity of the SAG-MHC Interaction on Sta-
1994; Labrecque et al., 1994). To determine whether Vability of the TCR-SAG-MHC Complex
CDR2 actually makes any contribution to stabilizing the(A) Sensograms showing the binding of wild-type SEC3 (SEC3 WT),
SEC3 3B1, and SEC3 3B2 to immobilized 14.3.d ab TCR in the TCR-SAG-MHC complex, we introduced point muta-
presence or absence of soluble HLA-DR1. 8 mM SEC3 WT, 6 mM tions at Va CDR2 positions 49, 51, and 54 of the 2C TCR
SEC3 3B1, or 6 mM SEC3 3B2 was injected over 3000 RU of immobi- and tested the effects of these mutations on complex
lized 14.3.d TCR, either alone (green) or mixed with 1.0 mM HLA-
formation. This TCR uses the same Vb as the 14.3.dDR1 (red).
TCR (Vb8.2) but a different Va (Va3.1). Unlike Va CDR2(B) Determination of the off-rate of the ternary complex formed by
Ser51, Va CDR2 Tyr49 and Pro54 are not predicted toSEC3 WT. 3 mM SEC3 WT was mixed with 0, 0.5, 0.75, 1.0, 1.25,
1.75, or 2.25 mM HLA-DR1 and injected over immobilized 14.3.d
TCR (2000 RU). A graphical representation of a single exponential
fit of the dissociation phases is inserted. The upper part of the insert
shows the experimental values as time points and the calculated (C) Determination of the off-rate of the ternary complex formed by
values as overlaid curves; the lower part displays the corresponding SEC3 3B. 6 mM SEC3 3B2 was injected over 1800 RU of immobilized
residuals (i.e., the difference between the experimental and calcu- 14.3.d TCR in combination with 1.5, 0.91, 0.56, 0.34, 0.21, or 0.13
lated values at each time point). mM HLA-DR1. Results are presented as in (B).
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Figure 5. Mutational Analysis of the Role of Va CDR2 in Stabilizing the TCR-SAG-MHC Complex
(A) Close-up of putative contacts between the Va domain of the 2C TCR (green) and the a-helix of the HLA-DR1 b1 domain (blue) in the model
of the TCR-SEC3-peptide/MHC class II complex in Figure 1. The side chains of Va CDR2 residues Tyr49, Ser51, and Pro54 and of DR1 b
chain residue Thr77 are shown in red.
(B) Equivalent concentrations of wild-type (WT) and mutant (Y49A, S51P, and P54A) 2C TCRs were injected over 500 RU of immobilized SEC3
3B2, either alone (green) or mixed with 0.5 mM HLA-DR1 (red). The identity of each 2C TCR mutant is indicated at the top of each overlay
plot.
form direct contacts to MHC in the ternary complex, SEC3 3B2 in order to obtain the same amount of bound
protein for each (Figure 5B). The experiment was thenalthough they are in proximity to the MHC b1 helix (Fig-
ure 5A). A single-chain version of the 2C TCR was ex- repeated using equivalent amounts of TCR in the pres-
ence of a fixed concentration (0.5 mM) of soluble HLA-pressed in bacterial inclusion bodies and refolded in
vitro as described (Schodin et al., 1996; Manning et al., DR1. The Va Y49A mutation resulted in a small, though
detectable, effect on ternary complex formation. The1998).
Like 14.3.d TCR, wild-type 2C TCR exhibited signifi- kinetics were slightly different than those of wild-type
2C TCR: the association phase reached a plateau soonercantly enhanced binding when injected over immobi-
lized SEC3 3B2 in combination with soluble HLA-DR1 and the off-rate was more rapid. The maximum response
was also somewhat reduced compared with wild-type.(Figure 5B). The dissociation kinetics for the mixture of
2C TCR and MHC were also clearly slower than for the In contrast, the Va S51P mutant displayed an almost
complete loss of enhanced binding and the off-rate wasTCR alone. As noted previously (Manning et al., 1998),
immobilization of single-chain 2C TCR to the sensor unaffected by the addition of HLA-DR1. Indeed, the sen-
sograms obtained for Va S51P in the presence or ab-surface led to its inactivation, which precluded reversing
the orientation of the assay, as was possible for 14.3.d sence of DR1 closely resemble those in Figure 2B for
the binding of isolated 14.3.d b chain to immobilizedTCR. However, our inability to reverse the orientation is
not a significant concern in this case, since in contrast SEC3, with or without MHC. Finally, the Va P54A muta-
tion had no detectable effect on complex formation.to the 14.3.d TCR from Drosophila cells, the 2C TCR did
not show any signs of aggregation when injected alone Thus, a single mutation at position 51 of Va CDR2 is
sufficient to eliminate the contribution of the a chain toover the immobilized SAG: the equilibrium binding level
was reached within seconds and the response rapidly stabilization of the TCR-SAG-MHC complex, whereas
mutations at Va CDR2 positions 49 or 54 have little orreturned to baseline upon completion of the injection
(compare Figures 2A and 5B). no effect. These results are consistent with our model
of the ternary complex (Figure 1) in which Va Ser51,We next compared the binding of wild-type 2C TCR
to immobilized SEC 3B2 with that of three point mutants located at the tip of the CDR2 loop, contacts the HLA-
DR1 b1 helix, but in which Va Ty49 and Pro54, althoughin Va CDR2: Y49A, S51P, and P54A. The Va S51P substi-
tution is one of three naturally occurring amino acid also part of the loop, do not participate in direct interac-
tions with MHC (Figure 5A).differences between Va3.1 and Va3.2 that are known
to influence CD4/CD8 lineage commitment (Sim et al., Although we do not know whether the serine-to-pro-
line substitution at position 51 of the 2C TCR a chain1996). After serine and threonine, proline is the most
frequently occurring residue at position 51 in mouse Va would reduce the reactivity to SEC3 or SEB of a T cell
bearing the mutant TCR, Smith et al. (1992) reportedregions (8% of all sequences, compared with 53% for
serine and 28% for threonine) (Clark et al., 1995). As that Vb8.11 hybridomas expressing Va11.1 were SEB
reactive, whereas Vb8.11 hybridomas expressing Va11.3expected from the crystal structure of the TCR b-SEC3
complex (Fields et al., 1996), these mutations did not were not. Since SEB is likely to bind Vb8.1 in the same
manner as Vb8.2 (the sequences of the two b chainsaffect the affinity of the 2C TCR for SEC3 alone (data
not shown). To permit a quantitative comparison, wild- are 90% identical), the Va domain of TCRs expressing
Vb8.1 should be oriented similarly with respect to thetype and mutant TCRs were first titrated on immobilized
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MHC b1 helix as the Va3.1 domain of the 2C TCR in the activation argue that the short half-lives of TCR-peptide/
MHC or TCR-SAG-MHC complexes are necessary tomodel of the TCR-SAG-MHC complex in Figure 1. A
comparison of the amino acid sequences of Va11.1 and enable a single ligand to serially engage a large number
of TCRs. It remains to be established, however, whetherVa11.3 reveals that Va11.1, like wild-type 2C a chain, has
a serine at position 51. However, Va11.3 has a proline at ligands that form complexes with very long half-lives
(minutes or hours) are actually less efficient at triggeringthis position, as does the 2C TCR mutant that does not
exhibit a chain-mediated stabilization of the TCR-SAG- T cells or whether ligands that form progressively more
stable complexes stimulate T cells increasingly well,MHC complex. The only other difference in the CDR2
sequences of Va11.1 and Va11.3 is a conservative ala- until some plateau of maximum stimulation is attained.
nine-to-valine substitution at position 50.
Experimental Procedures
Conclusions
Protein Expression and Purification
We have shown that the TCR a chain is required for Soluble 14.3.d TCR b chain was produced in J558L myeloma cells
maximum stabilization of the TCR-SAG-MHC complex and affinity purified as previously described (Bentley et al., 1995)
using the anti-mouse Cb monoclonal antibody H57-597 (Kubo etand that the a chain increases the half-life of the complex
al., 1989). Soluble 14.3.d ab TCR heterodimer was produced into a value comparable to those reported for TCR-pep-
Drosophila cells basically as described (Wallny et al., 1995). Thetide/MHC class I or class II complexes (Corr et al., 1994;
recombinant protein was purified from culture supernatants usingMatsui et al., 1994; Alam et al., 1996; Lyons et al., 1996;
antibody H57-597, followed by gel filtration on a Superdex 200 col-
Kersh et al., 1998). Since different TCR a chains can be umn (Pharmacia Biotech AB, Uppsala, Sweden) immediately before
expected to stabilize the TCR-SAG-MHC complex to BIAcore experiments to eliminate aggregated material that could
interfere with affinity measurements. The 14.3.d ab TCR was alsodifferent extents, this may explain the preferential ex-
purified by gel filtration before BIAcore. Wild-type and mutant 2Cpression of certain Va regions observed among T cells
single-chain TCRs were constructed as thioredoxin fusion proteinsreactive with a particular SAG. We have also demon-
with a His6 tag, using a PCR-based technique (Manning et al., 1998).strated that increasing the affinity of the SEC3-DR1 inter-
Proteins were expressed in E. coli strain GI698 and isolated from
action further stabilizes the TCR-SAG-MHC complex, inclusion bodies by denaturing affinity chromatography using His-
as predicted by a model involving direct TCR-MHC inter- Bind resin (Novagen). Following renaturation by dialysis (Schodin
et al., 1996), the monomeric proteins were purified by gel filtrationactions. By showing that a single amino acid change at
on a Superdex 200 column. Soluble HLA-DR1 was produced asposition 51 of Va CDR2 eliminates the contribution of
previously described (Stern and Wiley, 1992; Murthy and Stern,the a chain to ternary complex stabilization, we have
1997; Leder et al., 1998) using a recombinant baculovirus (pACDR1)identified this CDR as the likely site of interaction with
encoding both DRa and DRb1*0101 chains. The empty ab DR1
MHC. heterodimer was loaded with peptides HA 306-318 or YAK as de-
It is probably not coincidental that the half-life of the scribed (Stern and Wiley, 1992). Recombinant wild-type SEC3 was
prepared from Staphylococcus aureus strain FRI913 as describedTCR-SEC3-MHC class II complex falls within the range
(Blomster-Hautamaa and Schlievert, 1988).measured for specific TCR-peptide/MHC complexes.
This implies that SAGs have evolved to mimic the kinet-
Phage Display and Affinity Maturation of SEC3ics of interaction of peptide/MHC complexes with the
To obtain SEC3 variants with enhanced affinity for HLA-DR1, SEC3
TCR. To do so, SAGs have developed a novel strategy residues 43±47 (KFLAH) were randomized using degenerate oligo-
to compensate for their relatively low (compared with nucleotides PCR, and the resulting phage library selected by pan-
ning on immobilized DR1 molecules. To construct the library, theantigenic peptides) affinities for MHC. This involves
SEC3 gene was first amplified from a plasmid that harbors the genecross-linking TCR and MHC in such a way that the TCR
in its genomic configuration (Hovde et al., 1990) and subcloned intoVa domain is brought into proximity of the MHC class
the pCANTAB-5E vector (Pharmacia Biotech AB) using appropiateII b1 domain, permitting direct TCR-MHC interactions
DNA modifying enzymes. A single clone (pSEC3 WT) was chosen
that further stabilize the ternary complex. It is notewor- and used as template in subsequent PCR procedures. The N-termi-
thy that the rotational orientation of TCR and MHC mole- nal part of SEC3 was amplified with Vent DNA polymerase (New
England Biolabs) using primers PSA012 (AATTATTATTCGCAATTCCcules in our model of the TCR-SEB-MHC complex (Li
TTTAG, matching the pelB leader sequence) and PSA027 (GTTATAAet al., 1998) differs by about 408 from that in the TCR-
ATTAAATCSNNSNNSNNSNNSNNATCTACAGACATAA C, matchingpeptide/MHC complex (Garboczi et al., 1996; Ding et
the anti-sense strand of the region to be randomized). The C-termi-al., 1998; Garcia et al., 1998) and that there are no direct
nal part of the gene was similarly amplified using primers PSA026
contacts between the TCR b chain and MHC or between (AAAGTTATGTCTGTAGATNNSNNSNNSNNSNNSGATTTAATTTAT
bound peptide and the TCR combining site (Figure 1). AAC, matching the sense strand of the area to be randomized)
and PSA023 (ACTTTCAACAGTCTATGCGGC, complementary to theThis indicates that the specific geometry of TCR engage-
sequence of phage gene III located just downstream of the SEC3ment by a particular ligand may be less critical for T cell
gene). The two PCR products (215 and 678 bp, respectively) wereactivation than certain other factors, in particular the
gel purified and joined by PCR overlap extension using the flankingstability of the resulting complex (Kersh et al., 1998). It
primers PSA011 and PSA023. The full product (845 bp) was purified,
should be emphasized, however, that the half-lives of digested with SfiI and NotI, and ligated into pCANTAB-5E. The li-
both TCR-SAG-MHC and TCR-peptide/MHC complexes gated DNA was purified and electroporated into E. coli strain TG1.
The preparation of phage for selection experiments was carriedare far shorter than those reported for other ligand-
out essentially as described (Marks et al., 1991). The library wasreceptor complexes (e.g., antigen-antibody, homone-
selected using soluble HLA-DR1 immobilized on MaxiSorp plastichormone receptor, and cytokine-cytokine receptor),
microtiter plates (NUNC A/C, Roskilde, Denmark). MHC was dilutedwhose half-lives are measured in minutes or hours rather
to 20 mg/ml in PBS, and 200 ml was applied to four wells in a
than seconds. Indeed, the serial triggering (Valitutti et microtiter plate. The plate was left overnight at 48C. After blocking
al., 1995; Viola and Lanzavecchia, 1996) and kinetic the wells by filling them completely with PBS containing 2%
skimmed milk powder (SMP-PBS), 80 ml phage stock diluted 1:1 inproofreading (Rabinowitz et al., 1996) models of T cell
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SMP-PBS (approximately 5 3 1012 cfu) was applied to each HLA- together with 2 3 105 irradiated (10,000 rad) mouse L cells express-
ing HLA-DR1 as APC in the presence of varying amounts of differentDR1-coated well. The plate was slowly rotated at room temperature
at an angle of about 808 for 1.5 hr. Unbound phage were removed SAGs in 200 ml of IMDM supplemented with 10% FCS as duplicates
in flat-bottom 96-well plates. Syngeneic APCs were removed Dyna-by 10 washes with PBS containing 0.005% Tween-20 (PBS/Tween),
followed by 10 washes with PBS alone. Bound phage were eluted beads (Dynal A/S, Oslo, Norway) coated with the anti-MHC class II
monoclonal antibody M5/114 (Bhattacharya et al., 1981). After 48by incubation with 200 ml 0.1 M glycine-HCl (pH 2.2) for 10 min. The
eluate was immediately neutralized with 7 ml 2 M Tris base; half of or 72 hr of incubation at 378C, 1 mCi/well of [3H]thymidine was added
for the next 12 hr. Incorporation of radioactivity was then measuredthe eluate was used to infect log phase TG1 cells. An aliquot was
removed for titration after 1 hr at 378C to estimate the amount of using a Betaplate 1250 system (Wallacy, Turku, Finland).
infected cells, and the remaining cells were transferred into fresh
medium and grown to an optical density of 0.5±0.8. Helper phage
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